9 employees
Algorithmic Biologics develops software and technology to maximize molecular testing processes.
2021
Algorithmic Biologics raised undisclosed on July 4, 2023
Investors: Google Developers Launchpad Program
Algorithmic Biologics raised undisclosed on January 11, 2022
Investors: Axilor Ventures